---
title: "Ironwood Pharma 2026 年第一季度财报预览"
type: "News"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/285408430.md"
description: "Ironwood 医药（IRWD）将于 5 月 7 日公布其第一季度财报，市场普遍预期每股收益（EPS）为 0.24 美元，收入预期为 9210 万美元。历史上，IRWD 在过去两年中有 13% 的时间超出每股收益预期，50% 的时间超出收入预期"
datetime: "2026-05-06T16:03:18.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/285408430.md)
  - [en](https://longbridge.com/en/news/285408430.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/285408430.md)
---

# Ironwood Pharma 2026 年第一季度财报预览

Ironwood Pharmaceuticals (IRWD) is scheduled to announce Q1 earnings results on Thursday, May 7th, before market open. The consensus EPS Estimate is $0.24 and the consensus Revenue Estimate is $92.1M. Over the last 2 years, IRWD has beaten EPS estimates 13% of the time and has beaten revenue estimates 50% of the time. Over the last 3 months, EPS es...

### 相关股票

- [IRWD.US](https://longbridge.com/zh-CN/quote/IRWD.US.md)

## 相关资讯与研究

- [Ironwood 医药｜8-K：2026 财年 Q1 营收 1.07 亿美元超过预期](https://longbridge.com/zh-CN/news/285537526.md)
- [礼邦医药港交所 IPO：去年行政开支增幅超 300% 净亏损扩大](https://longbridge.com/zh-CN/news/287153722.md)
- [征祥医药赴港 IPO：营收 35 万，累计亏损约 2.9 亿 未来盈利任重道远](https://longbridge.com/zh-CN/news/286843416.md)
- [二季度竞速赛道，白银靠什么领跑发展？](https://longbridge.com/zh-CN/news/286757898.md)
- [金融产业日报 (05.20) : 全球债市抛售](https://longbridge.com/zh-CN/news/287110082.md)